New diabetes combo pill put to the test in healthy volunteers
NCT ID NCT07399470
First seen Feb 11, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study checks if a new single pill containing three diabetes medicines (gemigliptin, dapagliflozin, metformin) works the same in the body as taking the three drugs separately. It involves 58 healthy adults aged 19 to 50 who will receive both treatments in random order under fasting conditions. The goal is to compare how the drugs are absorbed and tolerated, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jeonbuk National University Hospital
Jeonju, Jeollabuk-do, 54907, South Korea
Conditions
Explore the condition pages connected to this study.